Perth Group

From AIDS Wiki
(Redirected from Eleni Papadopulos-Eleopulos)
Jump to: navigation, search
Eleni Papadopulos-Eleopulos
Valendar Turner

The Perth Group is a group of researchers formed in 1981 in Perth, Western Australia. The three original members are the leader, biophysicist Eleni Papadopulos-Eleopulos, emergency physician Valendar Turner, and Professor of Pathology John Papadimitriou.

Over the years several other scientists have contributed to or joined the Perth group of researchers. These are physicists Bruce Hedland-Thomas, David Causer and Barry Page, American biochemist Todd Miller and Colombian physician/medical researcher Helman Alfonso.

The Perth Group has argued that the existence of HIV as an exogenous retrovirus has never been proven, and they have posited a hypothesis of oxidative stress to explain both the illnesses of the clinical "AIDS syndrome" as well as the the phenomena interpreted by most as "HIV infection".

Scientific claims

Specifically, the Perth researchers' view is that the HIV/AIDS experts have not proven [the following is taken verbatim from the Perth Group website]:

  1. the existence of a unique, exogenously acquired retrovirus, HIV.
  2. the "HIV" antibody tests are specific for "HIV" infection.
  3. the HIV theory of AIDS, that is, that HIV causes acquired immune deficiency (destruction of T4 lymphocytes = AID) or that AID leads to the development of the clinical syndrome AIDS.
  4. the "HIV genome", (RNA or DNA) originates in a unique, exogenously acquired infectious retroviral particle.
  5. HIV/AIDS is infectious, either by blood, blood products or sexual intercourse.
  6. mother-to-child transmission of a retrovirus HIV or its inhibition with AZT or nevirapine.

They have also argued:

  1. the impossibility of haemophiliacs acquiring HIV following factor VIII infusions.
  2. that AIDS and all the phenomena inferred as "HIV" are induced by changes in cellular redox brought about by the oxidative nature of substances and exposures common to all the AIDS risk groups and to the cells used in the "culture" and "isolation" of "HIV".
  3. that AIDS will not spread outside the original risk groups.
  4. that the cessation of exposure to oxidants and/or use of anti-oxidants will improve the outcome of AIDS patients.
  5. that the pharmacological data prove AZT cannot kill "HIV" and AZT is toxic to all cells and may cause some cases of AIDS.


The Western blot test results vary according to geography. Click on this image for a full explanation of this figure compiled by Valendar Turner.
  • "What does one have to do and how hard does one have to plead in order to obtain answers to fundamental questions regarding a retrovirus which has menaced the world and in whose name hundreds of thousands of people have died or been poisoned?" — Eleni Papadopulos-Eleopulos, Valendar Turner, John Papadimitriou, and David Causer (Papadopulos-Eleopulos 1997)
  • "To prove the veracity of a blood test to detect pregnancy one compares positive and negative test results against the presence of absence of babies being born. In the case of a 100% accurate test one would expect all women who had babies to have a positive test and all women who did not have babies to have a negative test. In other words, the test parameters, including specificity for detecting pregnancy, are proven by using the baby as the 'gold standard'. In the case of 'HIV', the antibody tests are claimed to prove HIV infection. Hence the gold standard for such a test must be HIV itself, as proven by isolating the virus. In this case HIV is 'the baby' that authenticates whether or not the reactions between the antibodies and the test kit proteins are caused by infection with 'HIV'. This gold standard principle is used to verify tests throughout clinical medicine but has been ignored by the HIV/AIDS experts in regard to determining antibody test parameters for HIV infection.... HIV experts claim they can distinguish between 'true' (caused by HIV) and 'cross-reactions' (not caused by HIV) by using second, third and fourth generation antibody tests and arranging these into various test algorithms. By developing such methods they claim HIV infection can be diagnosed with the utmost accuracy. I reject such claims because no amount of 'technological tinkering' can obviate the fundamental need to verify all antibody tests, no matter what methods are used and in what arrangement they are conducted, against the virus isolation gold standard." — Valendar Turner (Turner 2006)
  • "The practice, widely adopted by HIV/AIDS experts, of appraising HIV antibody tests by testing thousands of healthy blood donors, also creates an enormous dilemma. If healthy people are regarded as a de facto gold standard for the absence of HIV infection, counting the occasional one or two who do react as false-positives, by what criteria can similar or even the same individuals be regarded as infected at some future date? One week the same individual may be tested as member of a cohort of healthy blood donors and the following week when he or she requests an examination for Life Insurance or attends a doctor for a checkup. Is this person HIV infected or not? Does the outcome depend solely upon who you are and which door you knock on?" — Valendar Turner (Turner 1996)
  • "Retroviral-like particles are practically ubiquitous. In the 1970s such particles were frequently observed in human leukaemia tissues, in cultures of embryonic tissues and in the majority of animal and human placentas. This is of significance given that the H9 cell line [a clone of the HUT78 cell line used by Gallo] is made up of leukaemic cells and also because Montagnier obtained his EMs [electron micrographs] from cultures done with umbilical cord blood lymphocytes. There's also a large group of retroviral particles classified as type-C particles that are found in fish, snakes, worms, pheasant, quail, partridge, turkey, tree mice, agouti, tapeworms, insects as well as mammals. And amongst its many official guises HIV has been described as a type-C particle, by both Montagnier and Gallo." — Eleni Papadopulos-Eleopulos (Johnson 1997)

Documents and external links



Scientific papers

Other articles and writings


The BMJ debate

Letters to the editor


Responses and commentaries


  • Geneva Presentation (1998)
  • Presentation on Nevirapine (2002)




  1. Johnson, Christine, 1997. Interview with Eleni Papadopulos-Eleopulos, Continuum, Autumn 1997.
  2. Papadopulos-Eleopulos E, Turner VF, Papadimitriou J, and Causer D, 1997. Reply to Duesberg (II), Continuum, February/March 1997.
  3. Turner, Valendar, 1996. Do HIV Antibody Tests Prove HIV Infection?, radio address.
  4. Turner, Valendar, 2006. Affidavit of Valendar Turner concerning the case of Andre Chad Parenzee PDFsmallicon.gif